Position in BIIB
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,268,786
+$1,485,202 QoQ
Shares Held
34,194
+25.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 18.38041761712581.ToString("F0")%
Shared 0.ToString("F0")%
None 81.61958238287419.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Generali Asset Management SPA SGR holds $342,656,021 across 9 Drug Manufacturers - General names. BIIB ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
954,783 | $188,302,303 | |
| 2 | LLY |
ELI LILLY & Co
|
62,651 | $57,624,510 | |
| 3 | MRK |
Merck & Co., Inc.
|
284,084 | $34,172,464 | |
| 4 | AMGN |
Amgen Inc
|
50,205 | $17,664,629 | |
| 5 | ABBV |
AbbVie Inc.
|
80,486 | $17,504,900 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
252,642 | $15,322,737 | |
| 7 | BIIB |
Biogen Inc.
This page
|
34,194 | $6,268,786 | |
| 8 | PFE |
Pfizer Inc
|
206,394 | $5,795,543 |
All Filings in BIIB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,268,786 | 34,194 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,783,584 | 27,181 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $5,732,774 | 40,925 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $5,234,842 | 41,682 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $5,359,201 | 39,164 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,476,539 | 16,195 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||